Home Services Technologies Resources News and Events Contact
Publications

2007

Ferrara, Joseph V., "Personalized Medicine: Challenging Pharmaceutical and Diagnostic Company Business Models", McGill Journal of Medicine, Vol 10, No 1, 2007

2006

Robbertz, A., Lauf, R., Rupp, R., Alexander, D., "A qualitative assessment of dental care access and utilization among the older adult population in the United States", AGD General Dentistry, September/October 2006, Vol 54, No 5

A Guide to US Reimbursement for Drugs, Medical Devices, and Diagnostics, D&MD Publications, April 2006, Report #9202
Updated: A comprehensive review of how medical technologies secure payment from private and public payers. The guide examines coverage, coding and payment issues from private payer (HMO, PPO) and public payer (Medicare, Medicaid) perspectives.

Ferrara, Joseph V., "Personalized Medicine: Challenges in Assessing and Capturing Value in the Commercial Environment", Expert Review of Molecular Diagnostics, Future Drugs, Ltd, March 2006, Vol 6, No 2

2005

Zick, C.D., Mathews, C.J., Roberts, J.S., Cook-Deegan, R., Pokorski, R.J., Green, R.C., "Genetic Testing For Alzheimer's Disease And Its Impact On Insurance Purchasing Behavior", Health Affairs, March/April edition, 2005

2004

Stewart, Maria B., "Reimbursement Q&A", UroTrends Newsletter, Spring 2004, Vol 9, No 1.

"Is there any easy way to ensure your molecular Dx is reimbursable?", SNPtech Pharmacogenomics Reporter, Perspectives, March 25, 2004, interview with Maria B. Stewart.

Anderson, D.Q. "Early-Stage Biotechnology Partnering and Deal Making - Drivers, Deals, and Direction for 2004", Drug & Market Development Newsletter, March 2004

2003

MX: Issues Update, "Coalition Urges Adoption of MIRA Reforms", October 2003, quoted by Jo Ellen Slurzberg

"A Guide To Achieving Reimbursement For Medical Devices, Diagnostics, and Pharmaceuticals in the United States", This Guide explores the basics of reimbursement and provides companies with the tools to navigate through this complex process.  In addition, the Guide highlights the latest policy and legislative initiatives that have significantly impacted the industry.

Anderson , D.Q. "Mergers and Acquisitions in the Healthcare Sector - Part 2: Medical Devices and Diagnostics", In Press, Drug & Market Development Newsletter, September 2003

Anderson , D.Q. "Mergers and Acquisitions in the Healthcare Sector - Part 1: Pharmaceuticals and Biotechnology", In Press, Drug & Market Development Newsletter, August 2003

Anderson , D.Q. "Adjustment issues", The Deal, 1 (26), May 19th, 2003

Anderson, D.Q. "Bio burnout", The Deal, 1 (18), March 24th, 2003

Anderson , D.Q. "Financial Crisis in the Biotechnology Industry", Drug & Market Development Newsletter, February 2003

Ferrara , J.V. "Is the current reimbursement structure limiting R&D in IVDs?", IVD Technology, 9 (1), January/February 2003

Next

Create. Navigate.®
About Us | Contact | Site Map
Boston Healthcare